These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10874690)

  • 1. Thyrotropin-releasing hormone and its receptor in the cerebellum of inferior olive destroyed rat brain.
    Adachi K; Rhue BN; Li M; Izumi M; Osano H; Mitsuma T
    Neurol Res; 2000 Jun; 22(4):401-3. PubMed ID: 10874690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olivocerebellar projections modify hereditary Purkinje cell degeneration.
    Tolbert DL; Clark BR
    Neuroscience; 2000; 101(2):417-33. PubMed ID: 11074164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebellar output regulation by the climbing and mossy fibers with and without the inferior olive.
    Bardin JM; Batini C; Billard JM; Buisseret-Delmas C; Conrath-Verrier M; Corvaja N
    J Comp Neurol; 1983 Feb; 213(4):464-77. PubMed ID: 6300201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of endotoxemia on thyrotropin releasing hormone and its receptor in Wistar rat brain].
    Wang XC; Liu BY; Xu P; Jing H
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Oct; 15(10):622-4. PubMed ID: 14552689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of immunoreactive thyrotropin-releasing hormone in the brain of patients with olivoponto-cerebellar atrophy.
    Mitsuma T; Nogimori T; Adachi K; Mukoyama M; Ando K; Sobue I
    J Neurol Sci; 1985 Dec; 71(2-3):369-75. PubMed ID: 3936904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of thyrotropin-releasing hormone in the brain of ataxic mice.
    Mitsuma T; Adachi K; Ando K
    J Neurol Sci; 1986 Sep; 75(2):135-9. PubMed ID: 3093641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone and its receptor in glia.
    Fernández-Agulló T
    Glia; 2001 Mar; 33(4):267-76. PubMed ID: 11246225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histydyl-proline diketopiperazine (HPD), a metabolite of thyrotropin-releasing hormone (TRH), improves the ataxic gait in 3-acetylpyridine (3-AP) treated rats].
    Kurahashi K; Kannari K; Kimura K; Matsunaga M; Takebe K
    No To Shinkei; 1986 Sep; 38(9):893-8. PubMed ID: 3790371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity.
    O'Hearn E; Molliver ME
    J Neurosci; 1997 Nov; 17(22):8828-41. PubMed ID: 9348351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic abnormalities caused by 3-acetylpyridine in the cerebral motor regions of rats: partial recovery by thyrotropin-releasing hormone.
    Kinoshita K; Watanabe Y; Asai H; Matsuoka Y
    Jpn J Pharmacol; 2000 Apr; 82(4):295-300. PubMed ID: 10875748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
    Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of immunoreactive thyrotropin releasing hormone in the lower brainstem of the rat.
    Eskay RL; Long RT; Palkovits M
    Brain Res; 1983 Oct; 277(1):159-62. PubMed ID: 6416609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central neurotoxic effects of intraperitoneally administered 3-acetylpyridine, harmaline and niacinamide in Sprague-Dawley and Long-Evans rats: a critical review of central 3-acetylpyridine neurotoxicity.
    Balaban CD
    Brain Res; 1985 Apr; 356(1):21-42. PubMed ID: 3158380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the climbing fibres essential for the Purkinje cell inhibitory action?
    Montarolo PG; Raschi F; Strata P
    Exp Brain Res; 1981; 42(2):215-8. PubMed ID: 6455300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOS expression in the brainstem and cerebellum following phencyclidine and MK801.
    Näkki R; Sharp FR; Sagar SM
    J Neurosci Res; 1996 Jan; 43(2):203-12. PubMed ID: 8820968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-thyrotropin-releasing hormone concentrations in the brain of ataxic mice.
    Mitsuma T; Adachi K; Mukoyama M; Ando K
    J Neurol Sci; 1990 Sep; 98(2-3):163-7. PubMed ID: 2123001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferior olive: its role in motor learing.
    Llinás R; Walton K; Hillman DE; Sotelo C
    Science; 1975 Dec; 190(4220):1230-1. PubMed ID: 128123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats.
    Kinoshita K; Watanabe Y; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1998 Feb; 343(2-3):129-33. PubMed ID: 9570459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of thyrotropin-releasing hormone (TRH) receptors in the brain of the ataxic mutant mouse, rolling mouse Nagoya.
    Kinoshita K; Yamamura M; Sugihara J
    Biol Pharm Bull; 1997 Jan; 20(1):86-7. PubMed ID: 9013814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topological relationship between corticotropin-releasing factor-immunoreactive cerebellar afferents and tyrosine hydroxylase-immunoreactive Purkinje cells in a hereditary ataxic mutant, rolling mouse Nagoya.
    Sawada K; Sakata-Haga H; Hisano S; Fukui Y
    Neuroscience; 2001; 102(4):925-35. PubMed ID: 11182254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.